SNBOSCI
ONCY

Security National Bank of Sioux City Iowa’s Oncolytics Biotech ONCY Stock Holding History

Security National Bank of Sioux City Iowa’s Portfolio ONCY Stock Details ONCY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$28.2K Hold
33,255
– – 0.02% 104
2025
Q4 		$29.1K Buy
+33,255
New +$35.9K 0.02% 90

Other funds holding ONCY

Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
SFP
Sandbox Financial Partners Bethesda, Maryland $356M AUM 19.83% 1-Year Est. Return
SI
Seeds Investor New York $973M AUM 33.7% 1-Year Est. Return
TAM
Tocqueville Asset Management New York $7.56B AUM 44.87% 1-Year Est. Return
EFG
Everhart Financial Group Dublin, Ohio $1.56B AUM 34.29% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
DA
Doliver Advisors Houston, Texas $442M AUM 34.09% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Security National Bank of Sioux City Iowa's ONCY Position: Q1 2026 in Review

Security National Bank of Sioux City Iowa held its Oncolytics Biotech (ONCY) position steady in Q1 2026 at 33,255 shares worth $28.2K. The position accounts for 0.02% of the portfolio, ranked #104.

Security National Bank of Sioux City Iowa first reported a position in ONCY in Q4 2025 and has held it in 2 quarters since. The position peaked at $29.1K in Q4 2025. 59 funds tracked by Wall St. Rank hold ONCY as of Q1 2026.

  • Security National Bank of Sioux City Iowa held 33,255 shares of Oncolytics Biotech worth $28.2K as of Q1 2026.
  • Security National Bank of Sioux City Iowa left its Oncolytics Biotech share count unchanged in Q1 2026.
  • Oncolytics Biotech made up 0.02% of Security National Bank of Sioux City Iowa's portfolio in Q1 2026, its #104 holding.
  • Security National Bank of Sioux City Iowa first reported a position in Oncolytics Biotech in Q4 2025 and has held it in 2 quarters since.
  • Security National Bank of Sioux City Iowa's Oncolytics Biotech position peaked at $29.1K in Q4 2025.
  • 59 funds tracked by Wall St. Rank held Oncolytics Biotech as of Q1 2026.

Based on Security National Bank of Sioux City Iowa's 13F filing for Q1 2026, filed 15 May 2026.